Developing a medical device-grade T2 phantom optimized for myocardial T2 mapping by cardiovascular magnetic resonance

被引:1
|
作者
Topriceanu, Constantin-Cristian [1 ,2 ,5 ]
Fornasiero, Massimiliano [3 ]
Seo, Han [4 ]
Webber, Matthew [1 ,2 ,4 ,5 ]
Keenan, Kathryn E. E. [6 ]
Stupic, Karl F. F. [6 ]
Bruehl, Ruediger [7 ]
Ittermann, Bernd [7 ]
Price, Kirsty [8 ]
McGrath, Louise [8 ]
Pang, Wenjie [9 ]
Hughes, Alun D. D. [2 ,5 ]
Nezafat, Reza [10 ]
Kellman, Peter [11 ]
Pierce, Iain [1 ,2 ]
Moon, James C. C. [1 ,2 ]
Captur, Gabriella [2 ,4 ,5 ,12 ]
机构
[1] Barts Hlth NHS Trust, Barts Heart Ctr, ECIA 7BE, London, England
[2] UCL, Inst Cardiovasc Sci, Huntley St, London WC1E 6DD, England
[3] UCL Med Sch, 74 Huntley St, London WC1E 6DE, England
[4] Royal Free London NHS Fdn Trust, Ctr Inherited Heart Muscle Condit, Dept Cardiol, Pond St, London NW3 2QG, England
[5] UCL, Med Res Council Unit Lifelong Hlth & Ageing, 1-19 Torrington Pl, London WC1E 7HB, England
[6] NIST, 325 Broadway, Boulder, CO 80305 USA
[7] Phys Tech Bundesanstalt PTB, Abbestr 2-12, D-10587 Berlin, Germany
[8] UCL Bloomsbury Ctr Clin Phenotyping, London WC1E 6HX, England
[9] Resonance Hlth RH, 141 Burswood Rd, Burswood, WA 6100, Australia
[10] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Div, 330 Brookline Ave, Boston, MA 02215 USA
[11] NHLBI, NIH, Bethesda, MD 20892 USA
[12] UCL, Inst Cardiovasc Sci, Inherited Heart Muscle Condit, Gower St, London WC1E 6BT, England
基金
英国医学研究理事会; 欧盟地平线“2020”; 英国经济与社会研究理事会;
关键词
T-1; mapping; T-2; Phantom; Quality control; MRI; FIELD; ECHO; SEQUENCES; VALUES; 3T;
D O I
10.1186/s12968-023-00926-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionA long T-2 relaxation time can reflect oedema, and myocardial inflammation when combined with increased plasma troponin levels. Cardiovascular magnetic resonance (CMR) T-2 mapping therefore has potential to provide a key diagnostic and prognostic biomarkers. However, T-2 varies by scanner, software, and sequence, highlighting the need for standardization and for a quality assurance system for T-2 mapping in CMR.AimTo fabricate and assess a phantom dedicated to the quality assurance of T-2 mapping in CMR.MethodA T-2 mapping phantom was manufactured to contain 9 T-1 and T-2 (T-1|T-2) tubes to mimic clinically relevant native and post-contrast T-2 in myocardium across the health to inflammation spectrum (i.e., 43-74 ms) and across both field strengths (1.5 and 3 T). We evaluated the phantom's structural integrity, B-0 and B-1 uniformity using field maps, and temperature dependence. Baseline reference T-1|T-2 were measured using inversion recovery gradient echo and single-echo spin echo (SE) sequences respectively, both with long repetition times (10 s). Long-term reproducibility of T-1|T-2 was determined by repeated T-1|T-2 mapping of the phantom at baseline and at 12 months.ResultsThe phantom embodies 9 internal agarose-containing T-1|T-2 tubes doped with nickel di-chloride (NiCl2) as the paramagnetic relaxation modifier to cover the clinically relevant spectrum of myocardial T-2. The tubes are surrounded by an agarose-gel matrix which is doped with NiCl2 and packed with high-density polyethylene (HDPE) beads. All tubes at both field strengths, showed measurement errors up to <= 7.2 ms [< 14.7%] for estimated T-2 by balanced steady-state free precession T-2 mapping compared to reference SE T-2 with the exception of the post-contrast tube of ultra-low T-1 where the deviance was up to 16 ms [40.0%]. At 12 months, the phantom remained free of air bubbles, susceptibility, and off-resonance artifacts. The inclusion of HDPE beads effectively flattened the B-0 and B-1 magnetic fields in the imaged slice. Independent temperature dependency experiments over the 13-38 degrees C range confirmed the greater stability of shorter vs longer T-1|T-2 tubes. Excellent long-term (12-month) reproducibility of measured T-1|T-2 was demonstrated across both field strengths (all coefficients of variation < 1.38%).ConclusionThe T-2 mapping phantom demonstrates excellent structural integrity, B-0 and B-1 uniformity, and reproducibility of its internal tube T-1|T-2 out to 1 year. This device may now be mass-produced to support the quality assurance of T-2 mapping in CMR.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Developing a medical device-grade T2 phantom optimized for myocardial T2 mapping by cardiovascular magnetic resonance
    Constantin-Cristian Topriceanu
    Massimiliano Fornasiero
    Han Seo
    Matthew Webber
    Kathryn E. Keenan
    Karl F. Stupic
    Rüdiger Bruehl
    Bernd Ittermann
    Kirsty Price
    Louise McGrath
    Wenjie Pang
    Alun D. Hughes
    Reza Nezafat
    Peter Kellman
    Iain Pierce
    James C. Moon
    Gabriella Captur
    Journal of Cardiovascular Magnetic Resonance, 25
  • [2] A MEDICAL DEVICE-GRADE T2 PHANTOM FOR QUALITY ASSURANCE OF INFLAMMATION IMAGING BY CMR
    Fornasiero, Massimiliano
    Pierce, Iain
    Webber, Matthew
    Keenan, Kathryn E.
    Stupic, Karl F.
    Bruehl, Rudiger
    Ittermann, Bernd
    Pang, Wenjie
    Hughes, Alun D.
    Nezafat, Reza
    Kellman, Peter
    Moon, James C.
    Captur, Gabriella
    HEART, 2021, 107 : A9 - A10
  • [3] THE ASSESSMENT OF REPERFUSION HAEMORRHAGE FOLLOWING ACUTE MYOCARDIAL INFARCTION BY T2 AND T2*CARDIOVASCULAR MAGNETIC RESONANCE
    Mather, A. N.
    Radjenovic, S.
    Greenwood, J. P.
    Plein, S.
    HEART, 2010, 96 : A45 - A46
  • [4] The assessment of reperfusion haemorrhage following acute myocardial infarction by T2 and T2* cardiovascular magnetic resonance
    Adam N Mather
    Aleksandra Radjenovic
    John P Greenwood
    Sven Plein
    Journal of Cardiovascular Magnetic Resonance, 12 (Suppl 1)
  • [5] T2 and T2* Mapping
    Welsch G.H.
    Hennig F.F.
    Krinner S.
    Trattnig S.
    Current Radiology Reports, 2 (8)
  • [6] Robust myocardial T2 and T2* mapping at 3T
    Arshad Zaman
    David M Higgins
    Marc Kouwenhoven
    Ananth Kidambi
    John P Greenwood
    Sven Plein
    Journal of Cardiovascular Magnetic Resonance, 14 (Suppl 1)
  • [7] A medical device grade T2 phantom to quality control inflammation imaging by CMR
    Seo, H. S.
    Captur, G.
    Ittermann, B.
    Pang, W.
    Keenan, K.
    Kellman, P.
    Nezafat, R.
    Chaturvedi, N.
    Hughes, A.
    Moon, J. C.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2019, 20 : 7 - 8
  • [8] Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy
    Gastl, Mareike
    Gruner, Christiane
    Labucay, Karin
    Gotschy, Alexander
    Von Spiczak, Jochen
    Polacin, Malgorzata
    Boenner, Florian
    Kelm, Malte
    Ruschitzka, Frank
    Alkadhi, Hatem
    Kozerke, Sebastian
    Manka, Robert
    OPEN HEART, 2020, 7 (01):
  • [9] T2*magnetic resonance and myocardial iron in thalassemia
    Pennell, DJ
    COOLEY'S ANEMIA EIGHTH SYMPOSIUM, 2005, 1054 : 373 - 378
  • [10] Reducing mortality by myocardial T2*cardiovascular magnetic resonance at national level
    Westwood, Mark A.
    Pennell, Dudley J.
    EUROPEAN HEART JOURNAL, 2022, 43 (26) : 2493 - 2495